13G

Company

Avalo Therapeutics, Inc.

Filed

May 17, 2022

Accession Number

0001929354-22-000002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →